Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Wealth planning tools are essential for financial success. Discover resources that can help you achieve your financial aspirations.
28,655 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A notable stake reduction by pacific ridge capital trims its NWPX position, signaling a shift in exposure. This guide...
Debt trends are shifting from policy tool to market risk. This report explains how the U.S. rose to financial promine...
As Tehran grapples with itself, global markets price in oil volatility and currency risk. Analysts say Iran sends con...
Two senior researchers depart the Ethereum Foundation, intensifying leadership churn. Market watchers split on whethe...
North Carolina lawmakers pass a landmark move to end most off-street parking requirements, citing lower housing costs...
A major fiduciary manager disclosed a sizable purchase in the Vanguard Long-Term Corporate Bond ETF, signaling a stra...
Former Detroit Mayor Mike Duggan suspends his Michigan governor bid amid rising fuel costs and a toxic partisan clima...
Borrowers with a 600 credit score face tighter lending, but flexible programs from a handful of lenders are expanding...
The crisis now in its third week intensified after a missile strike on the U.S. embassy in Baghdad and a fuel facilit...
Strategy stock essentially leveraged means the company borrows to buy Bitcoin, making its fate closely tied to crypto...
Lovesac’s Q1 2027 narrative offers clues about demand, margins, and strategy for the year ahead. This article breaks ...